| Literature DB >> 25738250 |
Kai-Uwe Eckardt1, Seth L Alper2, Corinne Antignac3,4, Anthony J Bleyer5, Dominique Chauveau6, Karin Dahan7, Constantinos Deltas8, Andrew Hosking9, Stanislav Kmoch10, Luca Rampoldi11, Michael Wiesener1, Matthias T Wolf12, Olivier Devuyst13.
Abstract
Rare autosomal dominant tubulointerstitial kidney disease is caused by mutations in the genes encoding uromodulin (UMOD), hepatocyte nuclear factor-1β (HNF1B), renin (REN), and mucin-1 (MUC1). Multiple names have been proposed for these disorders, including 'Medullary Cystic Kidney Disease (MCKD) type 2', 'Familial Juvenile Hyperuricemic Nephropathy (FJHN)', or 'Uromodulin-Associated Kidney Disease (UAKD)' for UMOD-related diseases and 'MCKD type 1' for the disease caused by MUC1 mutations. The multiplicity of these terms, and the fact that cysts are not pathognomonic, creates confusion. Kidney Disease: Improving Global Outcomes (KDIGO) proposes adoption of a new terminology for this group of diseases using the term 'Autosomal Dominant Tubulointerstitial Kidney Disease' (ADTKD) appended by a gene-based subclassification, and suggests diagnostic criteria. Implementation of these recommendations is anticipated to facilitate recognition and characterization of these monogenic diseases. A better understanding of these rare disorders may be relevant for the tubulointerstitial fibrosis component in many forms of chronic kidney disease.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25738250 DOI: 10.1038/ki.2015.28
Source DB: PubMed Journal: Kidney Int ISSN: 0085-2538 Impact factor: 10.612